The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Eperisone is a central muscle relaxant.Acting on the spinal cord and vascular smooth muscle, it can reduce the sensitivity of muscle spindle by inhibiting the spinal cord reflex, inhibiting the spontaneous impulse of the myomotor neurons, and thus relieving the tension of skeletal muscle.And through the expansion of blood vessels and improve blood circulation, from many aspects to block muscle tension hyperactivity → circulation disorder → muscle pain → muscle tension hyperactivity this kind of skeletal muscle tension vicious circle.
The global Eperisone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Eperisone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Eperisone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Eperisone include Navipharm, Daewon, Hanmi, Eisai, Bracco, Zambon, Hunan Yada Pharmaceutical and Qingdao Guohai Biopharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Eperisone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eperisone.
Report Scope
The Eperisone market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eperisone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eperisone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Navipharm
Daewon
Hanmi
Eisai
Bracco
Zambon
Hunan Yada Pharmaceutical
Qingdao Guohai Biopharmaceutical
Segment by Type
Particles
Tablets
Segment by Application
Neck Shoulder Wrist Syndrome
Shoulder Periarthritis
Lumbar Pains
Spastic Paralysis
Musculoskeletal Pain
Systemic Traumatic Pain
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eperisone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eperisone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Eperisone is a central muscle relaxant.Acting on the spinal cord and vascular smooth muscle, it can reduce the sensitivity of muscle spindle by inhibiting the spinal cord reflex, inhibiting the spontaneous impulse of the myomotor neurons, and thus relieving the tension of skeletal muscle.And through the expansion of blood vessels and improve blood circulation, from many aspects to block muscle tension hyperactivity → circulation disorder → muscle pain → muscle tension hyperactivity this kind of skeletal muscle tension vicious circle.
The global Eperisone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Eperisone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Eperisone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Eperisone include Navipharm, Daewon, Hanmi, Eisai, Bracco, Zambon, Hunan Yada Pharmaceutical and Qingdao Guohai Biopharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Eperisone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eperisone.
Report Scope
The Eperisone market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eperisone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eperisone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Navipharm
Daewon
Hanmi
Eisai
Bracco
Zambon
Hunan Yada Pharmaceutical
Qingdao Guohai Biopharmaceutical
Segment by Type
Particles
Tablets
Segment by Application
Neck Shoulder Wrist Syndrome
Shoulder Periarthritis
Lumbar Pains
Spastic Paralysis
Musculoskeletal Pain
Systemic Traumatic Pain
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eperisone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eperisone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Eperisone Market Overview
1.1 Product Overview and Scope of Eperisone
1.2 Eperisone Segment by Type
1.2.1 Global Eperisone Market Value Comparison by Type (2024-2030)
1.2.2 Particles
1.2.3 Tablets
1.3 Eperisone Segment by Application
1.3.1 Global Eperisone Market Value by Application: (2024-2030)
1.3.2 Neck Shoulder Wrist Syndrome
1.3.3 Shoulder Periarthritis
1.3.4 Lumbar Pains
1.3.5 Spastic Paralysis
1.3.6 Musculoskeletal Pain
1.3.7 Systemic Traumatic Pain
1.3.8 Other
1.4 Global Eperisone Market Size Estimates and Forecasts
1.4.1 Global Eperisone Revenue 2019-2030
1.4.2 Global Eperisone Sales 2019-2030
1.4.3 Global Eperisone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Eperisone Market Competition by Manufacturers
2.1 Global Eperisone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Eperisone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Eperisone Average Price by Manufacturers (2019-2024)
2.4 Global Eperisone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eperisone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eperisone, Product Type & Application
2.7 Eperisone Market Competitive Situation and Trends
2.7.1 Eperisone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Eperisone Players Market Share by Revenue
2.7.3 Global Eperisone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Eperisone Retrospective Market Scenario by Region
3.1 Global Eperisone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Eperisone Global Eperisone Sales by Region: 2019-2030
3.2.1 Global Eperisone Sales by Region: 2019-2024
3.2.2 Global Eperisone Sales by Region: 2025-2030
3.3 Global Eperisone Global Eperisone Revenue by Region: 2019-2030
3.3.1 Global Eperisone Revenue by Region: 2019-2024
3.3.2 Global Eperisone Revenue by Region: 2025-2030
3.4 North America Eperisone Market Facts & Figures by Country
3.4.1 North America Eperisone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Eperisone Sales by Country (2019-2030)
3.4.3 North America Eperisone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Eperisone Market Facts & Figures by Country
3.5.1 Europe Eperisone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Eperisone Sales by Country (2019-2030)
3.5.3 Europe Eperisone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eperisone Market Facts & Figures by Country
3.6.1 Asia Pacific Eperisone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Eperisone Sales by Country (2019-2030)
3.6.3 Asia Pacific Eperisone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Eperisone Market Facts & Figures by Country
3.7.1 Latin America Eperisone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Eperisone Sales by Country (2019-2030)
3.7.3 Latin America Eperisone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eperisone Market Facts & Figures by Country
3.8.1 Middle East and Africa Eperisone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Eperisone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Eperisone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eperisone Sales by Type (2019-2030)
4.1.1 Global Eperisone Sales by Type (2019-2024)
4.1.2 Global Eperisone Sales by Type (2025-2030)
4.1.3 Global Eperisone Sales Market Share by Type (2019-2030)
4.2 Global Eperisone Revenue by Type (2019-2030)
4.2.1 Global Eperisone Revenue by Type (2019-2024)
4.2.2 Global Eperisone Revenue by Type (2025-2030)
4.2.3 Global Eperisone Revenue Market Share by Type (2019-2030)
4.3 Global Eperisone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Eperisone Sales by Application (2019-2030)
5.1.1 Global Eperisone Sales by Application (2019-2024)
5.1.2 Global Eperisone Sales by Application (2025-2030)
5.1.3 Global Eperisone Sales Market Share by Application (2019-2030)
5.2 Global Eperisone Revenue by Application (2019-2030)
5.2.1 Global Eperisone Revenue by Application (2019-2024)
5.2.2 Global Eperisone Revenue by Application (2025-2030)
5.2.3 Global Eperisone Revenue Market Share by Application (2019-2030)
5.3 Global Eperisone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Navipharm
6.1.1 Navipharm Corporation Information
6.1.2 Navipharm Description and Business Overview
6.1.3 Navipharm Eperisone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Navipharm Eperisone Product Portfolio
6.1.5 Navipharm Recent Developments/Updates
6.2 Daewon
6.2.1 Daewon Corporation Information
6.2.2 Daewon Description and Business Overview
6.2.3 Daewon Eperisone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Daewon Eperisone Product Portfolio
6.2.5 Daewon Recent Developments/Updates
6.3 Hanmi
6.3.1 Hanmi Corporation Information
6.3.2 Hanmi Description and Business Overview
6.3.3 Hanmi Eperisone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hanmi Eperisone Product Portfolio
6.3.5 Hanmi Recent Developments/Updates
6.4 Eisai
6.4.1 Eisai Corporation Information
6.4.2 Eisai Description and Business Overview
6.4.3 Eisai Eperisone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eisai Eperisone Product Portfolio
6.4.5 Eisai Recent Developments/Updates
6.5 Bracco
6.5.1 Bracco Corporation Information
6.5.2 Bracco Description and Business Overview
6.5.3 Bracco Eperisone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bracco Eperisone Product Portfolio
6.5.5 Bracco Recent Developments/Updates
6.6 Zambon
6.6.1 Zambon Corporation Information
6.6.2 Zambon Description and Business Overview
6.6.3 Zambon Eperisone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zambon Eperisone Product Portfolio
6.6.5 Zambon Recent Developments/Updates
6.7 Hunan Yada Pharmaceutical
6.6.1 Hunan Yada Pharmaceutical Corporation Information
6.6.2 Hunan Yada Pharmaceutical Description and Business Overview
6.6.3 Hunan Yada Pharmaceutical Eperisone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hunan Yada Pharmaceutical Eperisone Product Portfolio
6.7.5 Hunan Yada Pharmaceutical Recent Developments/Updates
6.8 Qingdao Guohai Biopharmaceutical
6.8.1 Qingdao Guohai Biopharmaceutical Corporation Information
6.8.2 Qingdao Guohai Biopharmaceutical Description and Business Overview
6.8.3 Qingdao Guohai Biopharmaceutical Eperisone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qingdao Guohai Biopharmaceutical Eperisone Product Portfolio
6.8.5 Qingdao Guohai Biopharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eperisone Industry Chain Analysis
7.2 Eperisone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eperisone Production Mode & Process
7.4 Eperisone Sales and Marketing
7.4.1 Eperisone Sales Channels
7.4.2 Eperisone Distributors
7.5 Eperisone Customers
8 Eperisone Market Dynamics
8.1 Eperisone Industry Trends
8.2 Eperisone Market Drivers
8.3 Eperisone Market Challenges
8.4 Eperisone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Eperisone Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Eperisone Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Eperisone Market Competitive Situation by Manufacturers in 2023
Table 4. Global Eperisone Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Eperisone Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Eperisone Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Eperisone Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Eperisone Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Eperisone, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Eperisone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Eperisone, Product Type & Application
Table 12. Global Key Manufacturers of Eperisone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Eperisone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eperisone as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Eperisone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Eperisone Sales by Region (2019-2024) & (KG)
Table 18. Global Eperisone Sales Market Share by Region (2019-2024)
Table 19. Global Eperisone Sales by Region (2025-2030) & (KG)
Table 20. Global Eperisone Sales Market Share by Region (2025-2030)
Table 21. Global Eperisone Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Eperisone Revenue Market Share by Region (2019-2024)
Table 23. Global Eperisone Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Eperisone Revenue Market Share by Region (2025-2030)
Table 25. North America Eperisone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Eperisone Sales by Country (2019-2024) & (KG)
Table 27. North America Eperisone Sales by Country (2025-2030) & (KG)
Table 28. North America Eperisone Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Eperisone Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Eperisone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Eperisone Sales by Country (2019-2024) & (KG)
Table 32. Europe Eperisone Sales by Country (2025-2030) & (KG)
Table 33. Europe Eperisone Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Eperisone Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Eperisone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Eperisone Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Eperisone Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Eperisone Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Eperisone Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Eperisone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Eperisone Sales by Country (2019-2024) & (KG)
Table 42. Latin America Eperisone Sales by Country (2025-2030) & (KG)
Table 43. Latin America Eperisone Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Eperisone Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Eperisone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Eperisone Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Eperisone Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Eperisone Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Eperisone Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Eperisone Sales (KG) by Type (2019-2024)
Table 51. Global Eperisone Sales (KG) by Type (2025-2030)
Table 52. Global Eperisone Sales Market Share by Type (2019-2024)
Table 53. Global Eperisone Sales Market Share by Type (2025-2030)
Table 54. Global Eperisone Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Eperisone Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Eperisone Revenue Market Share by Type (2019-2024)
Table 57. Global Eperisone Revenue Market Share by Type (2025-2030)
Table 58. Global Eperisone Price (US$/G) by Type (2019-2024)
Table 59. Global Eperisone Price (US$/G) by Type (2025-2030)
Table 60. Global Eperisone Sales (KG) by Application (2019-2024)
Table 61. Global Eperisone Sales (KG) by Application (2025-2030)
Table 62. Global Eperisone Sales Market Share by Application (2019-2024)
Table 63. Global Eperisone Sales Market Share by Application (2025-2030)
Table 64. Global Eperisone Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Eperisone Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Eperisone Revenue Market Share by Application (2019-2024)
Table 67. Global Eperisone Revenue Market Share by Application (2025-2030)
Table 68. Global Eperisone Price (US$/G) by Application (2019-2024)
Table 69. Global Eperisone Price (US$/G) by Application (2025-2030)
Table 70. Navipharm Corporation Information
Table 71. Navipharm Description and Business Overview
Table 72. Navipharm Eperisone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Navipharm Eperisone Product
Table 74. Navipharm Recent Developments/Updates
Table 75. Daewon Corporation Information
Table 76. Daewon Description and Business Overview
Table 77. Daewon Eperisone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Daewon Eperisone Product
Table 79. Daewon Recent Developments/Updates
Table 80. Hanmi Corporation Information
Table 81. Hanmi Description and Business Overview
Table 82. Hanmi Eperisone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Hanmi Eperisone Product
Table 84. Hanmi Recent Developments/Updates
Table 85. Eisai Corporation Information
Table 86. Eisai Description and Business Overview
Table 87. Eisai Eperisone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Eisai Eperisone Product
Table 89. Eisai Recent Developments/Updates
Table 90. Bracco Corporation Information
Table 91. Bracco Description and Business Overview
Table 92. Bracco Eperisone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Bracco Eperisone Product
Table 94. Bracco Recent Developments/Updates
Table 95. Zambon Corporation Information
Table 96. Zambon Description and Business Overview
Table 97. Zambon Eperisone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Zambon Eperisone Product
Table 99. Zambon Recent Developments/Updates
Table 100. Hunan Yada Pharmaceutical Corporation Information
Table 101. Hunan Yada Pharmaceutical Description and Business Overview
Table 102. Hunan Yada Pharmaceutical Eperisone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Hunan Yada Pharmaceutical Eperisone Product
Table 104. Hunan Yada Pharmaceutical Recent Developments/Updates
Table 105. Qingdao Guohai Biopharmaceutical Corporation Information
Table 106. Qingdao Guohai Biopharmaceutical Description and Business Overview
Table 107. Qingdao Guohai Biopharmaceutical Eperisone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Qingdao Guohai Biopharmaceutical Eperisone Product
Table 109. Qingdao Guohai Biopharmaceutical Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Eperisone Distributors List
Table 113. Eperisone Customers List
Table 114. Eperisone Market Trends
Table 115. Eperisone Market Drivers
Table 116. Eperisone Market Challenges
Table 117. Eperisone Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Eperisone
Figure 2. Global Eperisone Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Eperisone Market Share by Type in 2023 & 2030
Figure 4. Particles Product Picture
Figure 5. Tablets Product Picture
Figure 6. Global Eperisone Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Eperisone Market Share by Application in 2023 & 2030
Figure 8. Neck Shoulder Wrist Syndrome
Figure 9. Shoulder Periarthritis
Figure 10. Lumbar Pains
Figure 11. Spastic Paralysis
Figure 12. Musculoskeletal Pain
Figure 13. Systemic Traumatic Pain
Figure 14. Other
Figure 15. Global Eperisone Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Eperisone Market Size (2019-2030) & (US$ Million)
Figure 17. Global Eperisone Sales (2019-2030) & (KG)
Figure 18. Global Eperisone Average Price (US$/G) & (2019-2030)
Figure 19. Eperisone Report Years Considered
Figure 20. Eperisone Sales Share by Manufacturers in 2023
Figure 21. Global Eperisone Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Eperisone Players: Market Share by Revenue in 2023
Figure 23. Eperisone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Eperisone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Eperisone Sales Market Share by Country (2019-2030)
Figure 26. North America Eperisone Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Eperisone Sales Market Share by Country (2019-2030)
Figure 30. Europe Eperisone Revenue Market Share by Country (2019-2030)
Figure 31. Germany Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Eperisone Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Eperisone Revenue Market Share by Region (2019-2030)
Figure 38. China Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Eperisone Sales Market Share by Country (2019-2030)
Figure 49. Latin America Eperisone Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Eperisone Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Eperisone Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Eperisone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Eperisone by Type (2019-2030)
Figure 59. Global Revenue Market Share of Eperisone by Type (2019-2030)
Figure 60. Global Eperisone Price (US$/G) by Type (2019-2030)
Figure 61. Global Sales Market Share of Eperisone by Application (2019-2030)
Figure 62. Global Revenue Market Share of Eperisone by Application (2019-2030)
Figure 63. Global Eperisone Price (US$/G) by Application (2019-2030)
Figure 64. Eperisone Value Chain
Figure 65. Eperisone Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
